FI48098C - Menetelmä 6-halogeeni-4-oksa-3-okso-androstaanijohdannaisten valmistam iseksi - Google Patents

Menetelmä 6-halogeeni-4-oksa-3-okso-androstaanijohdannaisten valmistam iseksi

Info

Publication number
FI48098C
FI48098C FI683140A FI314068A FI48098C FI 48098 C FI48098 C FI 48098C FI 683140 A FI683140 A FI 683140A FI 314068 A FI314068 A FI 314068A FI 48098 C FI48098 C FI 48098C
Authority
FI
Finland
Prior art keywords
oxa
halo
oxo
preparation
androstane derivatives
Prior art date
Application number
FI683140A
Other languages
English (en)
Swedish (sv)
Other versions
FI48098B (fi
Inventor
Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI48098B publication Critical patent/FI48098B/fi
Application granted granted Critical
Publication of FI48098C publication Critical patent/FI48098C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
    • GPHYSICS
    • G11INFORMATION STORAGE
    • G11BINFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI683140A 1967-11-03 1968-11-04 Menetelmä 6-halogeeni-4-oksa-3-okso-androstaanijohdannaisten valmistam iseksi FI48098C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (2)

Publication Number Publication Date
FI48098B FI48098B (fi) 1974-02-28
FI48098C true FI48098C (fi) 1974-06-10

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI683140A FI48098C (fi) 1967-11-03 1968-11-04 Menetelmä 6-halogeeni-4-oksa-3-okso-androstaanijohdannaisten valmistam iseksi

Country Status (14)

Country Link
AT (2) AT297236B (fi)
BE (1) BE723189A (fi)
BR (1) BR6803654D0 (fi)
CH (1) CH505855A (fi)
DK (1) DK131576C (fi)
ES (1) ES359842A1 (fi)
FI (1) FI48098C (fi)
FR (2) FR1605466A (fi)
GB (1) GB1247022A (fi)
IE (1) IE33567B1 (fi)
IL (1) IL30879A (fi)
NL (1) NL6815623A (fi)
NO (1) NO132101C (fi)
SE (1) SE352360B (fi)

Also Published As

Publication number Publication date
NO132101C (fi) 1975-09-17
NO132101B (fi) 1975-06-09
DE1805857A1 (de) 1969-06-26
FR1605466A (fi) 1976-05-14
BE723189A (fi) 1969-04-30
IE33567L (en) 1969-05-03
IL30879A0 (en) 1968-12-26
BR6803654D0 (pt) 1973-01-16
FR8435M (fi) 1971-07-15
DE1805857B2 (de) 1977-06-23
IL30879A (en) 1972-11-28
NL6815623A (fi) 1969-05-06
GB1247022A (en) 1971-09-22
ES359842A1 (es) 1970-06-16
IE33567B1 (en) 1974-08-21
AT287932B (de) 1971-02-10
SE352360B (fi) 1972-12-27
DK131576B (da) 1975-08-04
CH505855A (de) 1971-04-15
FI48098B (fi) 1974-02-28
DK131576C (da) 1976-01-05
AT297236B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
SE382065B (sv) Forfarande for framstellning av linkomycinderivat
FI48727C (fi) Menetelmä asetyyliguanidiinien valmistamiseksi.
FI48746C (fi) Menetelmä tetrapolymeerilateksin valmistamiseksi.
FI49971C (fi) Menetelmä mikrobeja tuhoavien 2-nitrofurfurylideeni-indanonijohdannais ten valmistamiseksi.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI50409C (fi) Menetelmä pyridiini-karboksyylihappojen valmistamiseksi
FI47575C (fi) Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI50975C (fi) Menetelmä pyratsiiniamidi-johdannaisten valmistamiseksi.
FI50407C (fi) Menetelmä trikloorimonosilaanien valmistamiseksi
FI48088C (fi) Menetelmä 5-fenyyli-1H-1,4-bentsodiatsepiini-johdannaisten valmistamis eksi
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
FI48090C (fi) Menetelmä 1-syaaniaminoalkyyli-2H-1,4-bentsodiatsepiini-2-oni-johdanna isten valmistamiseksi
FI48724C (fi) Menetelmä N-karbamoyylioksifenyylikarbamaattien valmistamiseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI48098C (fi) Menetelmä 6-halogeeni-4-oksa-3-okso-androstaanijohdannaisten valmistam iseksi
FI51544C (fi) Menetelmä makeutusaineseosten valmistamiseksi.
SE343302B (sv) Foerfarande foer framstaellning av bensomorfanderivat
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.
FI49412C (fi) Menetelmä substituoitujen 3-amino-sydnoni-imiinien valmistamiseksi.
SE333149B (sv) Foerfarande foer framstaellning av bensimidazol-n-oxider
FI46722C (fi) Menetelmä 1alfa-hydroksi-18-metyyli-5alfa-H-androstaanijohdannaisten v almistamiseksi.
FI51202C (fi) Menetelmä 3-tioloitujen kefalosporiinijohdannaisten valmistamiseksi
FI50879C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-aminoasyyliam ino-tiofeenien valmistamiseksi.